Relapse after stages III-IV Tx is worse (4-yr EFS/OS: 42% vs. 48%, respectively), lung only mets: 4-yr EFS/OS: 49% vs. 53%, respectively. (GreenDM et al., Ped Blood Cancer 2007; MalogolowkinM et al., Ped Blood Cancer 2008)